RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
4.540
0.00 (0.00%)
Nov 6, 2026, 4:00 PM EST - Market closed
RxSight Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 121.83 | 134.48 | 139.93 | 89.08 | 49.01 | 22.59 | |
Revenue Growth | -14.26% | -3.89% | 57.08% | 81.77% | 116.90% | 53.92% |
Cost of Revenue | 29.08 | 31.47 | 40.98 | 35.31 | 27.68 | 18.08 |
Gross Profit | 92.75 | 103.01 | 98.94 | 53.77 | 21.33 | 4.52 |
Selling, General & Admin | 117.38 | 112.66 | 101.52 | 74.9 | 58.99 | 33.1 |
Research & Development | 36.82 | 38.54 | 34.28 | 28.95 | 25.66 | 24.2 |
Operating Expenses | 154.2 | 151.2 | 135.8 | 103.85 | 84.65 | 57.3 |
Operating Income | -61.46 | -48.19 | -36.86 | -50.09 | -63.32 | -52.79 |
Interest Expense | -0.01 | -0.02 | -0.02 | -3.31 | -4.95 | -3.68 |
Interest & Investment Income | 8.24 | 9.33 | 9.47 | 6.57 | 1.52 | 0.05 |
Other Non Operating Income (Expenses) | - | - | - | - | - | 7.74 |
EBT Excluding Unusual Items | -53.23 | -38.88 | -27.41 | -46.82 | -66.75 | -48.68 |
Other Unusual Items | - | - | - | -1.77 | - | - |
Pretax Income | -53.23 | -38.88 | -27.41 | -48.59 | -66.75 | -48.68 |
Income Tax Expense | 0.13 | 0.07 | 0.05 | 0.02 | 0.01 | 0.01 |
Earnings From Continuing Operations | - | -38.94 | -27.46 | -48.61 | -66.76 | -48.69 |
Net Income | -53.36 | -38.94 | -27.46 | -48.61 | -66.76 | -48.69 |
Net Income to Common | -53.36 | -38.94 | -27.46 | -48.61 | -66.76 | -48.69 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 41 | 41 | 39 | 34 | 28 | 14 |
Shares Outstanding (Diluted) | 41 | 41 | 39 | 34 | 28 | 14 |
Shares Change | 1.90% | 5.10% | 12.81% | 24.56% | 103.02% | 146.28% |
EPS (Basic) | -1.29 | -0.95 | -0.71 | -1.41 | -2.41 | -3.57 |
EPS (Diluted) | -1.29 | -0.95 | -0.71 | -1.41 | -2.41 | -3.57 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 18.65 | -19.34 | -22.39 | -46.41 | -61.24 | -46.65 |
Free Cash Flow Per Share | 0.45 | -0.47 | -0.58 | -1.35 | -2.21 | -3.42 |
Gross Margin | 76.13% | 76.60% | 70.71% | 60.36% | 43.52% | 19.99% |
Operating Margin | -50.44% | -35.84% | -26.34% | -56.23% | -129.21% | -233.64% |
Profit Margin | -43.80% | -28.96% | -19.62% | -54.57% | -136.22% | -215.50% |
Free Cash Flow Margin | 15.30% | -14.38% | -16.00% | -52.10% | -124.97% | -206.47% |
EBITDA | -57.84 | -44.93 | -33.28 | -46.01 | -59.43 | -48.81 |
EBITDA Margin | -47.48% | -33.41% | -23.79% | -51.65% | -121.28% | -216.05% |
D&A For EBITDA | 3.61 | 3.27 | 3.58 | 4.08 | 3.88 | 3.98 |
EBIT | -61.46 | -48.19 | -36.86 | -50.09 | -63.32 | -52.79 |
EBIT Margin | -50.44% | -35.84% | -26.34% | -56.23% | -129.21% | -233.64% |